Maze Therapeutics Revenue

Biotechnology Research • South San Francisco, California, United States • 101-200 Employees

Maze Therapeutics revenue & valuation

Annual revenue	$7,500,000
Revenue per employee	$54,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$24,000,000
Total funding	$645,000,000

Key Contacts at Maze Therapeutics

Kim Buck

Associate Director, Head Of Talent Acquisition

Daniel Aragon

Associate Director Of Fp&A

Arlito C. Legaspi

Senior Director, Facilities, Eh&S & Lab Operations

Mark Newman

Senior Director Business Development

Adebola Giwa

Senior Medical Director

Jason Holcomb

Associate Director, Clinical Quality Assurance

Rishabh Jain

Senior Director, Regulatory

Kevin Mellem

Director, Medicinal Chemistry

Rita Humeniuk

Senior Director, Clinical Pharmacology

Oscar Alcantar

Sr. Director, Head Of Clinical Operations

Company overview

Headquarters	171 Oyster Point Blvd, Suite 300, South San Francisco, California 94080, US
Phone number	+16508505070
Website	mazetx.com
NAICS	541714
SIC	873
Founded	2018
Employees	101-200
Socials

Maze Therapeutics Email Formats

Maze Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@mazetx.com), used 83.8% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@mazetx.com	83.8%
{first initial}{last name}	jdoe@mazetx.com	15.2%

About Maze Therapeutics

Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. The company’s pipeline is led by two wholly owned lead programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease. Maze is based in South San Francisco.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Director

Entry

Senior

Employees by Department

Maze Therapeutics has 71 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore Maze Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2022-02-10	1	$190,000,000
2022-02-10	6	$190,000,000
2025-01-03	7	$115,000,000
2025-10-11	14	$150,000,000

Funding Insights

$645,000,000

Total funding amount

$150,000,000

Most recent funding amount

Number of funding rounds

Maze Therapeutics Tech Stack

Discover the technologies and tools that power Maze Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Amazon Web Services

PaaS

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Nginx

Reverse proxies

Apple iCloud Mail

Webmail

PHP

Programming languages

React

JavaScript frameworks

WordPress

Blogs

Sectigo

SSL/TLS certificate authorities

OWL Carousel

JavaScript libraries

Google Analytics

Analytics

Moove GDPR Consent

Cookie compliance

Frequently asked questions

Maze Therapeutics is located in South San Francisco, California, US.

You can reach Maze Therapeutics at +16508505070.

Maze Therapeutics generates an estimated annual revenue of $7,500,000. This revenue figure reflects the company's market position and business performance in its industry.

Maze Therapeutics has an estimated valuation of $24,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Maze Therapeutics was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Maze Therapeutics has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Maze Therapeutics has raised a total of $645,000,000 across 4 funding rounds. This investment has helped the company grow and expand its operations.